Zalcal 20 CMD Solution for Injection

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Buy It Now

Active ingredient:

Boric Acid, Calcium, Glucose, Magnesium

Available from:

Listow Limited

ATC code:

QA12AX

INN (International Name):

Boric Acid, Calcium, Glucose, Magnesium

Authorization status:

Expired

Summary of Product characteristics

                                Revised: October 2012
AN: 00838/2012
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Zalcal 20 CMD Solution for Injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 400 ml vial contains
:
ACTIVE SUBSTANCE:
Contains: Calcium Borogluconate
20% w/v
Magnesium Hypophosphite Hexahydrate
5% w/v
Glucose Monohydrate
22% w/v
Each 400ml contains:
5.92g calcium (provided by calcium gluconate and calcium
borogluconate)
1.84g magnesium (provided by magnesium hypophosphate hexahydrate)
80g glucose as glucose monohydrate
Also contains 3.40% w/v boric acid.
EXCIPIENT:
Chlorocresol 0.10% w/v
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Solution for injection
A clear pale, yellow solution
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Sheep
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of hypocalcaemia complicated by deficiency of
magnesium with
accompanying hypoglycaemia. In the treatment of pregnancy toxaemia and
other
metabolic imbalances in periparturient sheep
Page 1 of 4
Revised: October 2012
AN: 00838/2012
4.3
CONTRAINDICATIONS
Not to be administered by intravenous or intramuscular routes
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
No special warning.
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
The solution should be warmed to body temperature before
administration.
ii.
Special precautions to be taken by the person administering the
veterinary
medicinal product to animals
Care should be taken to avoid accidental self-injection.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Can be safely administered to pregnant and lactating animals
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known
4.9
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
The solution should be warmed to body temperature before
administration by
subcutaneous injection only. Observe aseptic precautions. Sites of
administration
should be massaged gently.
Sheep
                                
                                Read the complete document